Schisandrol A Suppresses Catabolic Factor Expression by Blocking NF-κB Signaling in Osteoarthritis

• Главные авторы: Seong Jae Han (Автор), Jimoon Jun (Автор), Seong-il Eyun (Автор), Choong-Gu Lee (Автор), Jimin Jeon (Автор), Cheol-Ho Pan (Автор)
• Формат: ‌
• Опубликовано: MDPI AG, 2021-03-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Schisandrol A possesses pharmacological properties and is used to treat various diseases; however, its effects on osteoarthritis (OA) progression remain unclear. Here, we investigated Schisandrol A as a potential therapeutic agent for OA. In vitro, Schisandrol A effects were confirmed based on the l...